TRIVEHEXIN is one of the 24 subtypes of Integrin. It is a potent initiator of TGF-β activation, which drives tumor invasion and metastasis.
It is expressed by epithelial cells and is overproduced in carcinomas and fibrotic tissues.
Areas of Use
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Head and neck cancers (HNSCC)
- Idiopathic pulmonary fibrosis (IPF)
- Non-small cell lung cancers (NSCLC)